Morgan Stanley Holds ASML Rating, Cites Limited Upside

Key Analyst Rating and Forecast

Morgan Stanley has maintained its "overweight" rating on ASML Holding NV, keeping its price target firm at €1,400. However, the brokerage issued a note of caution, highlighting potentially limited near-term upside for the stock leading into 2026.

Analysis of Near-Term Outlook

The firm's analysis points to a specific challenge in the demand cycle for ASML's advanced extreme ultraviolet (EUV) lithography machines. Projections indicate that demand is heavily weighted toward the second half of 2026, which could temper stock performance in the interim. For the upcoming first-quarter results due on April 15, Morgan Stanley expects an in-line report, forecasting sales of €8.64 billion. This figure is at the high end of ASML's own guidance of €8.2 billion to €8.9 billion.

Implications for Investors

While the long-term "overweight" rating suggests confidence in ASML's fundamental strength, the forecast implies that investors may need to temper short-term growth expectations. The timing of EUV system orders will be a critical factor for the stock's trajectory over the next year.

Conclusion and Forward Look

In summary, ASML's long-term prospects remain positive according to Morgan Stanley's analysis. Nonetheless, the market will be closely watching the company's Q1 results and any commentary on future order books to gauge the accuracy of the near-term outlook.

FAQ

Q: What is Morgan Stanley's current rating and price target for ASML?
A: Morgan Stanley maintained an "overweight" rating on ASML with a price target of €1,400.

Q: Why does Morgan Stanley see limited near-term upside for ASML?
A: The limited upside is attributed to expectations that demand for its EUV lithography machines will be concentrated in the second half of 2026.

Source: Investing.com